Advanced Medical Solutions Group (LON:AMS)‘s stock had its “add” rating reiterated by analysts at Numis Securities in a report released on Wednesday. They currently have a GBX 340 ($4.44) price target on the stock. Numis Securities’ price objective would suggest a potential upside of 8.63% from the company’s current price.

AMS opened at GBX 313 ($4.09) on Wednesday. The stock has a market cap of $668.19 million and a P/E ratio of 30.99. Advanced Medical Solutions Group has a fifty-two week low of GBX 248.50 ($3.25) and a fifty-two week high of GBX 373.50 ($4.88).

Advanced Medical Solutions Group Company Profile

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the advanced wound care, surgical, and wound closure markets worldwide. It operates through two segments, Branded and OEM. The company offers natural and synthetic polymers for use in advanced wound care dressings under the ActivHeal brand; medical adhesives for closing and sealing tissue under the LiquiBand brand name; and sutures and haemostats for the medical device market under the RESORBA brand.

Recommended Story: How do candlesticks reflect price movement?

Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.